Camlin Fine Sciences Ltd — Capital/Financing Update 2021

Nov 17, 2021

==> picture [100 x 31] intentionally omitted <==

Date: November 17, 2021

To, To, BSE Limited , The Manager, 25, P. J. Towers, Listing Department, Dalal Street, National Stock Exchange of India Ltd ., Mumbai – 400 001 Exchange Plaza, Bandra Kurla Complex, Ref: Company Scrip Code: 532834 Bandra (East), Mumbai‐ 400051 Ref: Symbol : CAMLINFINE || Series: EQ

Dear Sir/Madam,

Sub: Disclosure of events or information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”)

This is with reference to our intimation dated February 8, 2021 wherein the Company had informed regarding approval of the Board of Directors for further acquisition of upto 35% stake in subsidiary namely, Dresen Quimica S.A.P.I. DE C.V. (“ Dresen ”) from Controladora De Servicios Riso S.A.P.I. de C.V. (“ joint venture partner ”).

Pursuant to the aforesaid approval the Company, through its newly incorporated wholly owned subsidiary in Mexico namely, CFS de Mexico Blends, S.A.P.I. DE C.V. ( CFS Blends ), has acquired 33.50% stake from the joint venture partner for an consideration amount of USD 8.50 million (US Dollars Eight Million Five Hundred Thousand).

The Company (along with CFS Blends) now holds 98.50% stake in Dresen. The details required under the SEBI LODR Regulations are annexed herewith.

This is for your information and record please.

Thanking you, For Camlin Fine Sciences Limited Santosh Parab Chief Financial Officer

==> picture [426 x 57] intentionally omitted <==